|
1
|
Roa JC, García P, Kapoor VK, Maithel SK,
Javle M and Koshiol J: Gallbladder cancer. Nat Rev Dis Primers.
8:692022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Levy AD, Murakata LA and Rohrmann CA Jr:
Gallbladder carcinoma: Radiologic-pathologic correlation.
Radiographics. 21:295–314. 549–555. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hundal R and Shaffer EA: Gallbladder
cancer: Epidemiology and outcome. Clin Epidemiol. 6:99–109.
2014.
|
|
4
|
Margonis GA, Gani F, Buettner S, Amini N,
Sasaki K, Andreatos N, Ethun CG, Poultsides G, Tran T, Idrees K, et
al: Rates and patterns of recurrence after curative intent
resection for gallbladder cancer: A multi-institution analysis from
the US extra-hepatic biliary malignancy consortium. HPB (Oxford).
18:872–878. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jarnagin WR, Ruo L, Little SA, Klimstra D,
D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH and Fong Y:
Patterns of initial disease recurrence after resection of
gallbladder carcinoma and hilar cholangiocarcinoma: Implications
for adjuvant therapeutic strategies. Cancer. 98:1689–1700. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Valle J, Wasan H, Palmer DH, Cunningham D,
Anthoney A, Maraveyas A, Madhusudan S, Iveson T, Hughes S, Pereira
SP, et al: Cisplatin plus gemcitabine versus gemcitabine for
biliary tract cancer. N Engl J Med. 362:1273–1281. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun J, Xie TG, Ma ZY, Wu X and Li BL:
Current status and progress in laparoscopic surgery for gallbladder
carcinoma. World J Gastroenterol. 29:2369–2379. 2023. View Article : Google Scholar
|
|
8
|
Campbell WA IV and Makary MS: Advances in
image-guided ablation therapies for solid tumors. Cancers (Basel).
16:25602024. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Slovak R, Ludwig JM, Gettinger SN, Herbst
RS and Kim HS: Immuno-thermal ablations-boosting the anticancer
immune response. J Immunother Cancer. 5:782017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bäcklund M and Freedman J: Microwave
ablation and immune activation in the treatment of recurrent
colorectal lung metastases: A case report. Case Rep Oncol.
10:383–387. 2017. View Article : Google Scholar
|
|
11
|
Xu H, Sun W, Kong Y, Huang Y, Wei Z, Zhang
L, Liang J and Ye X: Immune abscopal effect of microwave ablation
for lung metastases of endometrial carcinoma. J Cancer Res Ther.
16:1718–1721. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shao C, Yang M, Pan Y, Xie D, Chen B, Ren
S and Zhou C: Case report: Abscopal effect of microwave ablation in
a patient with advanced squamous NSCLC and resistance to
immunotherapy. Front Immunol. 12:6967492021. View Article : Google Scholar
|
|
13
|
Jiang G, Song C, Xu Y, Wang S, Li H, Lu R,
Wang X, Chen R, Mao W and Zheng M: Recurrent lung adenocarcinoma
benefits from microwave ablation following multidisciplinary
treatments: A case with long-term survival. Front Surg.
9:10382192023. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Saxena M, van der Burg SH, Melief CJM and
Bhardwaj N: Therapeutic cancer vaccines. Nat Rev Cancer.
21:360–378. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
He N and Jiang J: Contribution of immune
cells in synergistic anti-tumor effect of ablation and
immunotherapy. Transl Oncol. 40:1018592024. View Article : Google Scholar
|
|
16
|
Takashima ME, Berg TJ and Morris ZS: The
effects of radiation dose heterogeneity on the tumor
microenvironment and anti-tumor immunity. Semin Radiat Oncol.
34:262–271. 2024. View Article : Google Scholar
|
|
17
|
Zeng P, Shen D, Shu W, Min S, Shu M, Yao
X, Wang Y and Chen R: Identification of a novel peptide targeting
TIGIT to evaluate immunomodulation of 125I seed
brachytherapy in HCC by near-infrared fluorescence. Front Oncol.
13:11432662023. View Article : Google Scholar
|
|
18
|
Wang H, Shi HB, Qiang WG, Wang C, Sun B,
Yuan Y and Hu WW: CT-guided radioactive 125I seed
implantation for abdominal incision metastases of colorectal
cancer: Safety and efficacy in 17 patients. Clin Colorectal Cancer.
22:136–142. 2023.PubMed/NCBI
|
|
19
|
Chu KF and Dupuy DE: Thermal ablation of
tumours: Biological mechanisms and advances in therapy. Nat Rev
Cancer. 14:199–208. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yu M, Pan H, Che N, Li L, Wang C, Wang Y,
Ma G, Qian M, Liu J, Zheng M, et al: Microwave ablation of primary
breast cancer inhibits metastatic progression in model mice via
activation of natural killer cells. Cell Mol Immunol. 18:2153–2164.
2021. View Article : Google Scholar
|
|
21
|
den Brok MH, Sutmuller RP, van der Voort
R, Bennink EJ, Figdor CG, Ruers TJ and Adema GJ: In situ tumor
ablation creates an antigen source for the generation of antitumor
immunity. Cancer Res. 64:4024–4029. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ahmad F, Gravante G, Bhardwaj N,
Strickland A, Basit R, West K, Sorge R, Dennison AR and Lloyd DM:
Changes in interleukin-1β and 6 after hepatic microwave tissue
ablation compared with radiofrequency, cryotherapy and surgical
resections. Am J Surg. 200:500–506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhou W, Yu M, Mao X, Pan H, Tang X, Wang
J, Che N, Xie H, Ling L, Zhao Y, et al: Landscape of the peripheral
immune response induced by local microwave ablation in patients
with breast cancer. Adv Sci (Weinh). 9:e22000332022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang F, Wu J, Hong L, Zhang P and Song J:
Iodine-125 seed inhibits proliferation and promotes apoptosis of
cholangiocarcinoma cells by inducing the ROS/p53 axis. Funct Integr
Genomics. 24:1142024. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu W, Du P, Yang C, Jiang F, Xie P, Yang
J, Zhang Z and Ma J: The effect of computed tomography-guided
125I radioactive particle implantation in treating
cancer and its pain. Cancer Biother Radiopharm. 33:176–181.
2018.PubMed/NCBI
|
|
26
|
Sugawara A, Nakashima J, Kunieda E, Nagata
H, Mizuno R, Seki S, Shiraishi Y, Kouta R, Oya M and Shigematsu N:
Incidence of seed migration to the chest, abdomen, and pelvis after
transperineal interstitial prostate brachytherapy with loose (125)I
seeds. Radiat Oncol. 6:1302011. View Article : Google Scholar
|
|
27
|
Zhang G, Wu Z, Yu W, Lyu X, Wu W, Fan Y,
Wang Y, Zheng L, Huang M, Zhang Y, et al: Clinical application and
accuracy assessment of imaging-based surgical navigation guided
125I interstitial brachytherapy in deep head and neck regions. J
Radiat Res. 63:741–748. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ji Z, Ni Y, He C, Huo B, Liu S, Ma Y, Song
Y, Hu M, Zhang K, Wang Z, et al: Clinical outcomes of radioactive
seed brachytherapy and microwave ablation in inoperable stage I
non-small cell lung cancer. Am J Cancer Res. 13:3753–3762.
2023.PubMed/NCBI
|
|
29
|
Chen L, Zhu GY, Jin ZC, Zhong BY, Wang Y,
Lu J, Pan T, Teng GJ and Guo JH: Efficacy and safety of radioactive
125I seed implantation for patients with
oligo-recurrence soft tissue sarcomas. Cardiovasc Intervent Radiol.
45:808–813. 2022. View Article : Google Scholar
|
|
30
|
Zaorsky NG, Davis BJ, Nguyen PL, Showalter
TN, Hoskin PJ, Yoshioka Y, Morton GC and Horwitz EM: The evolution
of brachytherapy for prostate cancer. Nat Rev Urol. 14:415–439.
2017. View Article : Google Scholar
|
|
31
|
Charpentier M, Spada S, Van Nest SJ and
Demaria S: Radiation therapy-induced remodeling of the tumor immune
microenvironment. Semin Cancer Biol. 86:737–747. 2022. View Article : Google Scholar
|
|
32
|
Cao W, Chen G, Wu L, Yu KN, Sun M, Yang M,
Jiang Y, Jiang Y, Xu Y, Peng S and Han W: Ionizing radiation
triggers the antitumor immunity by inducing gasdermin E-mediated
pyroptosis in tumor cells. Int J Radiat Oncol Biol Phys.
115:440–452. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siva S, MacManus MP, Martin RF and Martin
OA: Abscopal effects of radiation therapy: A clinical review for
the radiobiologist. Cancer Lett. 356:82–90. 2015. View Article : Google Scholar
|
|
34
|
Hashimoto K, Nishimura S, Shinyashiki Y,
Ito T, Kakinoki R and Akagi M: Clinicopathological assessment of
PD-1/PD-L1 immune checkpoint expression in desmoid tumors. Eur J
Histochem. 67:36882023. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhou Y, Xu X, Ding J, Jing X, Wang F, Wang
Y and Wang P: Dynamic changes of T-cell subsets and their relation
with tumor recurrence after microwave ablation in patients with
hepatocellular carcinoma. J Cancer Res Ther. 14:40–45. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liu Q, Sun Z and Chen L: Memory T cells:
Strategies for optimizing tumor immunotherapy. Protein Cell.
11:549–564. 2020. View Article : Google Scholar
|
